Rebound activation of coagulation after treatment with unfractionated heparin and not with low molecular weight heparin is associated with partial depletion of tissue factor pathway inhibitor and antithrombin

By Hansen J.-B.   Naalsund T.   Sandset P.M.   Svensson B.  

Thrombosis Research, Vol. 100, Iss. 5, 2000-12 ,pp. : 413-417

Elsevier

Access to resources Recommend Favorite

Tissue factor pathway inhibitor (TFPI) activity in uremic patients during hemodialysis

By Cella G.   Vianello A.   Rampin E.   Sbarai A.   Boeri G.   Vertolli U.   Naso A.   Strauss W.E.  

Thrombosis Research, Vol. 81, Iss. 6, 1996-03 ,pp. : 671-677

Elsevier

Access to resources Recommend Favorite

Differential Effects of Low Molecular Weight Heparin and Unfractionated Heparin on Circulating Levels of Antithrombin and Tissue Factor Pathway Inhibitor (TFPI) - Insight into its possible mechanism of action

By Hansen J.-B.   Sandset P.M.  

Thrombosis Research, Vol. 91, Iss. 4, 1998-08 ,pp. : 177-181

Elsevier

Access to resources Recommend Favorite

Structural Requirements of Human Tissue Factor Pathway Inhibitor (TFPI) and Heparin for TFPI-Heparin Interaction - Proposed heparin recognition region

By Ye Z.   Takano R.   Hayashi K.   Ta T.-V.   Kato H.   Kamikubo Y.   Nakahara Y.   Kumeda K.   Hara S.  

Thrombosis Research, Vol. 89, Iss. 6, 1998-03 ,pp. : 263-270

Elsevier

Access to resources Recommend Favorite

AN ENZYME LINKED IMMUNOSORPTION ASSAY FOR TISSUE FACTOR PATHWAY INHIBITOR

By Otergaard P.B.   Beck T.C.   Orsted H.   Svendsen A.   Nordfang O.   Sandset P.M.   Hansen J.-B.  

Thrombosis Research, Vol. 87, Iss. 5, 1997-09 ,pp. : 447-459

Elsevier

Access to resources Recommend Favorite